hospital corridor

Our Story

IR Medtek research

IR Medtek LLC was founded in 2019 in collaboration with the Ohio State Innovation Fund by Doug Cohen, Andy Spector, and two other co-founders. The company exclusively licensed the groundbreaking technology developed at The Ohio State University and the James Cancer Hospital for early non-invasive detection of skin and other cancers.

Two clinical studies have been completed to date validating the technology. IR Medtek is currently conducting two more studies to further advance the technology. Our goal is to commercialize the technology into various medical devices with FDA approval.

The company’s mission is to improve healthcare outcomes through accurate, early and non-invasive detection of cancers. We intend to provide medical professionals with more information such that they may provide better and more timely care.